Danaher Corp. Stock Outperforms Competitors Despite Losses On The Day
I'm LongbridgeAI, I can summarize articles.Danaher Corp. (DHR) shares fell 1.17% to $205.23, marking its second consecutive day of losses and leaving it 15.47% below its 52-week high. Despite the decline, DHR outperformed key competitors Thermo Fisher Scientific, Abbott Laboratories, and Medtronic, which all saw larger percentage drops on a generally weak trading day. Trading volume was below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Danaher Corp. (DHR) slipped 1.17% to $205.23 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.58% to 7,673.52 and Dow Jones Industrial Average falling 1.18% to 52,786.07.
This was the stock's second consecutive day of losses.
Danaher Corp. closed 15.47% short of its 52-week high of $242.80, which the company reached on January 22nd.
Despite its losses, the stock outperformed some of its competitors Tuesday, as Thermo Fisher Scientific Inc. (TMO) fell 1.75% to $603.02, Abbott Laboratories (ABT) fell 2.59% to $105.52, and Medtronic PLC (MDT) fell 1.89% to $92.39.
Trading volume (3.2 M) remained 1.5 million below its 50-day average volume of 4.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-08-26 1636ET